Importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or in...

by Simões,Belinda Pinto, Braga Junior,José Wilson Ramos, Rego,Maria Aparecida do Carmo, Souza,Cármino Antônio de
Published 2011

Dasatinib: clinical trials and management of adverse events in imatinib resistant/intolerant chronic myeloid leukemia

by Conchon,Monika, Freitas,Carla Maria Boquimpani de Moura, Rego,Maria Aparecida do Carmo, Braga Junior,José Wilson Ramos
Published 2011